Guideline Current FIGO 2018
FIGO 2018 Cervical Cancer Staging
FIGO 2018 revised staging system for cervical carcinoma. Incorporates MRI-derived tumor size, parametrial invasion, pelvic side-wall involvement, and nodal disease.
Structured reportUpdated Jul 5, 2026
Applies to
- Biopsy-proven cervical carcinoma undergoing staging
Classification
- FIGO stage I
- FIGO stage II
- FIGO stage III
- FIGO stage IV
Exclusions
None listed
Interactive
Decision tree
Enter a finding to compute a recommendation without leaving the page.
Recommendation builder
Select the FIGO 2018 stage derived from MRI and clinical assessment.
FAQ
Frequently asked
Does this guideline apply to oncology patients?
No — patients with known malignancy fall outside the scope unless the guideline states otherwise. Follow oncologic surveillance protocols instead.
